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BRIEF REPORT
High arachis hypogaea allergen
2 immunoglobulin E levels
predict responses to exposure
to a small amount of peanut
protein
Food-speciﬁc immunoglobulin (IgE) concentra-
tions can be used to predict clinical allergies (1),
but there has been less research on how to predict
the severity of an allergic reaction (2). Studies of
milk allergies have shown a correlation between
the IgE levels in reaction to cows’ milk protein
and the severity of the allergic reaction as a result
of food challenges (3). Previously, no correlation
has been proposed between arachis hypogaea
allergen 2 (Ara h 2) levels and the severity of
peanut allergies (4).
This study primarily evaluated the predictive
power of Ara h 2 IgE in relation to the
threshold dose in a peanut challenge.
A total of 36 children with a high suspicion
of peanut allergies underwent open food chal-
lenges with peanuts. All participants were
sensitised to peanuts (Ara h 2 IgE >
0.35 kU/L) and the mean Ara h 2 level was
35.7 kU/L (range 0.40–260 kU/L). The chal-
lenge was performed according to the practical
allergy recommendations from the European
Academy of Allergy and Clinical Immunology
and the American Academy of Allergy, Asthma
and Immunology (5). This involved using
peanut protein doses of 5, 25, 50, 200 and
1000 mg, with a cumulative protein dose of
1280 mg. The reaction was assessed using
dose-adjusted severity scoring in the 21 (58%)
of patients with a positive oral food challenge.
We analysed serum Ara h 2 IgE levels and
their association with the cumulative protein
dose, also known as the threshold dose, the
severity of the response and the use of
adrenaline during the challenge. Patients were
divided into two groups according to whether
their Ara h 2 IgE levels were less than or at
least 10 kU/L (Table 1). SPSS Statistics
version 22.0 (IBM Corp, Armonk, New York,
USA) was used in the analysis of the
results. The Ethics Committee of Helsinki
University Hospital, Finland, approved the
study.
The groups were identical in terms of the age
and sex of the participants (Table 1). The
Spearman test (r) showed that Ara h 2 IgE
correlated with the cumulative protein dose or
threshold dose (r = 0.439, p = 0.023) but not
with reaction severity (r = 0.091, p = 0.348) or
with the use of adrenaline (r = 0.300,
p = 0.093). Children with an Ara h 2 IgE of
<10 kU/L had higher threshold doses than
children with a higher level (median 480 mg
versus 42.5 mg and mean 644 versus 71 mg,
p = 0.016). There were no signiﬁcant differ-
ences in the severity of the reactions or the use
of adrenaline between the two groups (Table 1).
We conclude that the Ara h 2 IgE level
predicted the peanut exposure threshold dose. A
low threshold dose increased the risk of an
allergic reaction as a result of accidental
exposure, which may lead to a severe real-
world reaction.
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Table 1 Patient characteristics according to Ara h 2 IgE
Group Ara h2 IgE <10 kU/L (n = 13) Ara h2 IgE ≥10 kU/L (n = 8) Significance
Age (years), Mean, Range 7.6, 3.39–14.32 8.3, 5.58–11.51 0.611 x
Sex (male) 7 (54%) 5(63%) 0.528 xx
Reaction intensity
Mild 5 (39%) 1 (13%) 0.346 xx
Intermediate/severe 8 (62%) 7 (88%) 0.346 xx
Use of adrenaline 3 (23%) 4 (50%) 0.215 xx
Cumulative peanut dose in
challenge (mg) median, range
480 (30–1280) 42.5 (30–230) 0.016 xxx
x, Independent sample T-test; xx, Fischer exact test; xxx, Mann-Whitney U Test.
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